HLL Lifecare Limited (HLL), a Miniratna public sector enterprise under the Ministry of Health and Family Welfare (MoHFW), has paid a dividend of ₹69.53 crore to the Government of India for the financial year 2024–25, reaffirming its strong financial performance and contribution to India’s public
In a major breakthrough for India’s medical device sector, the government has stepped in to avert a looming healthcare and supply chain crisis The intervention, led by the Department of Pharmaceuticals (DoP) and the Ministry of Steel, comes as a major relief to manufacturers grappling
The healthcare and life sciences sectors are now bracing for global ripple effects as the Trump administration, under President Donald J. Trump’s second term, enforces a new round of tariffs targeting imports from key trade partners, including India and China. The proposed 25% tariff on
Domestic manufacturers welcome greater market access, urge careful monitoring of import dynamics and regulatory alignment India’s medical device manufacturers have voiced their support for the proposed India-UK Free Trade Agreement (FTA), citing expanded opportunities for global collaboration and technology transfer. However, industry stakeholders also stressed the
The second edition of the India Health Exhibition 2025, organised by Informa Markets in India, was inaugurated today at Bharat Mandapam, New Delhi, highlighting the rising demand and immense potential in this sector. The three-day event, which concludes on 13th July 2025, returns with renewed
Policy Mahotsav 2.0, held on 23rd May 2025 at the Constitution Club of India, concluded with resounding success, reinforcing India’s pivotal role in shaping the global MedTech narrative. Centered on the theme “Policy, Regulation, and Public Good: Building the MedTech Industry for Tomorrow’s Healthcare,” the
In a significant policy development, the Government of Gujarat has reversed its earlier decision to exempt stents from the purview of central pricing regulation under the Clinical Establishments Act. This comes after broad-based feedback and concern from industry stakeholders, patient advocacy groups, and healthcare experts.Simultaneously,
The Association of Indian Medical Device Industry (AiMeD) has raised strong objections to a recent notification issued on March 10, 2025, by the Commissionerate of Health, Medical Services & Medical Education, Government of Gujarat. The notification sets an unjust reimbursement structure, allocating ₹25,000 for USFDA-approved
The Association of Indian Medical Device Industry (AiMeD) today emphasized the need for the Indian government to revisit tariff structures considering the ongoing efforts to enhance healthcare security in India and address potential challenges arising from global health crises.In a statement, AiMeD expressed concern over
Medical devices exports growth exceeds imports, govt move will prove to be shot-in-the-armThe Rs 500 crore MedTech scheme announced by the government on Friday will help the domestic players in the medical equipment industry to restart manufacturing and even become exporters. They had become
